US/EU companies that protect their drug brands in turn protect our lives. We need other countries to do more and we need to help them in doing so.

Some activist groups' rhetoric hurts the search for an AIDS cure.

The process of treating HIV patients in Africa has improved markedly due to cooperation between pharmaceutical companies, which has led to increasing access to higher quality medicines.

Ensuring that there are profits to be made from HIV/AIDS is probably the best way to keep companies investing and researching.

Poor nationsshould reject theanti-intellectual property and anti-pharmaceutical company stance that, in a resource-poor setting, is unlikely to be helpful ineither the shortor long terms.